WallStreetZenWallStreetZen

NASDAQ: ACRV
Acrivon Therapeutics Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Acrivon Therapeutics revenue was $0.00 for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q1 2025) ending on Mar 31, 2025 was $0.0, down N/A from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, ACRV annual revenue was $0.0, with N/A growth year-over-year.

ACRV revenue history

Current Revenue
$0.0
Current Earnings
-$83.8M
Current Profit Margin
0%

Be the first to know when ACRV announces revenue.

ACRV Revenue History By Year

ACRV Yearly RevenueACRV RevenueACRV ChangeACRV Revenue Growth
2024-12-31$0.00N/AN/A
2023-12-31$0.00N/AN/A
2022-12-31$0.00N/AN/A
2021-12-31$0.00N/AN/A
2020-12-31$0.00N/AN/A

1 of 1

Acrivon Therapeutics Revenue FAQ

What was ACRV's revenue last quarter?

Acrivon Therapeutics (NASDAQ: ACRV) reported Q1 2025 revenue of $0.00 up N/A year over year. In the same quarter last year, Acrivon Therapeutics's revenue was $0.00.

What was Acrivon Therapeutics's revenue in 2024?

Acrivon Therapeutics's annual revenue for the twelve months ending Dec 31, 2024 was $0.00, a N/A decrease year over year.

How much does Acrivon Therapeutics make in a day?

Based on Acrivon Therapeutics annual revenue for the past four years, ACRV makes an average of $0.00 per day.

What was Acrivon Therapeutics's annual revenue growth in the past year?

As of Q2 2025, Acrivon Therapeutics's revenue has grown null year over year. Acrivon Therapeutics's revenue in the past year totaled $0.00.

How much does Acrivon Therapeutics make in a year?

Acrivon Therapeutics's revenue by year for the past four years is:
  • Acrivon Therapeutics's revenue for the twelve months ending Dec 31, 2024 was $0.00, a N/A decrease year over year.
  • Acrivon Therapeutics's annual revenue for Dec 31, 2023 was $0.00, a N/A decrease from 2022.
  • Acrivon Therapeutics's annual revenue for 2022 was $0.00, a N/A decrease from 2021.
  • Acrivon Therapeutics's annual revenue for 2021 was $0.00, a N/A decrease from 2020.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.